Читать книгу Interventional Cardiology - Группа авторов - Страница 230

Interactive multiple choice questions are available for this chapter on www.wiley.com/go/dangas/cardiology References

Оглавление

1 1 Bom N, Lancee CT, Honkoop J, Hugenholtz PG. Ultrasonic viewer for crosss sectional analyses of moving cardiac structures. Biomed Eng 1971; 6(11): 500–503, 505. PubMed PMID: 5133281.

2 2 Bom N, Lancee CT, Van Egmond FC. An ultrasonic intracardiac scanner. Ultrasonics 1972; 10(2): 72–76. PubMed PMID: 5017589.

3 3 Yock PG, Linker DT, Angelsen BA. Two‐dimensional intravascular ultrasound: technical development and initial clinical experience. J Am Soc Echocardiogr 1989; 2(4): 296–304. PubMed PMID: 2697308.

4 4 Räber L, Mintz GS, Koskinas KC, et al. ESC Scientific Document Group. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018 Sep 14; 39(35):3281–3300. doi: 10.1093/eurheartj/ehy285. Erratum in: Eur Heart J. 2019 Jan 14; 40(3):308. PMID: 29790954.]

5 5 [Johnson TW, Räber L, di Mario C, et a. lClinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision‐making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2019 Aug 14; 40(31):2566–2584. doi: 10.1093/eurheartj/ehz332. PMID: 31112213.]

6 6 Mintz G. Intracoronary Ultrasound. Taylor & Francis, Abingdon, UK:2005.

7 7 Siegel RJ, Chae JS, Maurer G, et al. Histopathologic correlation of the three‐layered intravascular ultrasound appearance of normal adult human muscular arteries. Am Heart J 1993; 126(4): 872–878. PubMed PMID: 8213444.

8 8 Nishimura RA, Edwards WD, Warnes CA, et al. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol 1990; 16(1): 145–154. PubMed PMID: 2193046.

9 9 Velican D, Velican C. Comparative study on age‐related changes and atherosclerotic involvement of the coronary arteries of male and female subjects up to 40 years of age. Atherosclerosis 1981; 38(1‐2): 39–50. PubMed PMID: 7470204.

10 10 Isner JM, Donaldson RF, Fortin AH, et al. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol 1986; 58(10): 937–939. PubMed PMID: 3776849.

11 11 Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically “normal” coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995; 25(7): 1479–1485. PubMed PMID: 7759694.

12 12 Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316(22): 1371–1375. PubMed PMID: 3574413.

13 13 Losordo DW, Rosenfield K, Kaufman J, et al. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis: in vivo documentation using intravascular ultrasound. Circulation 1994; 89(6): 2570–2577. PubMed PMID: 8205666.

14 14 Mintz GS, Kent KM, Pichard AD, et al. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses: an intravascular ultrasound study. Circulation 1997; 95(7): 1791–1798. PubMed PMID: 9107165.

15 15 Schoenhagen P, Ziada KM, Kapadia SR, et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000; 101(6): 598–603. PubMed PMID: 10673250.

16 16 Inaba S, Mintz GS, Farhat NZ, et al. Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT. JACC Cardiovasc Imaging 2014; 7(1): 70–78. PubMed PMID: 24433710.

17 17 Wu X, Mintz GS, Xu K, et al. The relationship between attenuated plaque identified by intravascular ultrasound and no‐reflow after stenting in acute myocardial infarction: the HORIZONS‐AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv 2011; 4(5): 495–502. PubMed PMID: 21596321.

18 18 Lee SY, Mintz GS, Kim SY, et al. Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post‐percutaneous coronary intervention complications in patients with acute coronary syndromes. JACC Cardiovasc Interv 2009; 2(1): 65–72. PubMed PMID: 19463400.

19 19 Pu J, Mintz GS, Biro S, et al. Insights into echo‐attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near‐infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments. J Am Coll Cardiol 2014; 63(21): 2220–2233. PubMed PMID: 24681142.

20 20 Shiono Y, Kubo T, Tanaka A, et al. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST‐segment elevation myocardial infarction. JACC Cardiovasc Interv 2013; 6(8): 847–853. PubMed PMID: 23871509.

21 21 Xu K, Mintz GS, Kubo T, et al. Long‐term follow‐up of attenuated plaques in patients with acute myocardial infarction: an intravascular ultrasound substudy of the HORIZONS‐AMI trial. Circ Cardiovasc Interv 2012; 5(2): 185–192. PubMed PMID: 22438429.

22 22 Stone GW, Maehara A, Lansky AJ, et al. PROSPECT Investigators. A prospective natural‐history study of coronary atherosclerosis. N Engl J Med. 2011 Jan 20; 364(3):226–35. doi: 10.1056/NEJMoa1002358. Erratum in: N Engl J Med. 2011 Nov 24;365(21):2040. PMID: 21247313.

23 23 Dohi T, Mintz GS, McPherson JA, et al. Non‐fibroatheroma lesion phenotype and long‐term clinical outcomes: a substudy analysis from the PROSPECT study. JACC Cardiovasc Imaging 2013; 6(8): 908–916. PubMed PMID: 23850249.

24 24 Calvert PA, Obaid DR, O’Sullivan M, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH‐ IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011; 4(8): 894–901. PubMed PMID: 21835382.

25 25 Souza CF, Maehara A, Mintz GS, et al. Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study. Catheter Cardiovasc Interv. 2017 Dec 1; 90(7):1107–1114. doi: 10.1002/ccd.26954. Epub 2017 Feb 13. PMID: 28191713.

26 26 Elvin Kedhi. Combined Optical Coherence Tomography and Fractional Flow Reserve Assessment to BetterPredict Adverse Event Outcomes in DM Patients: COMBINE (OCT–FFR) Trial. Presented at: TCT 2020. October 14, 2020.

27 27 David Erlinge. PROSPECT II: A Prospective Natural History Study Using NIRS‐IVUS Imaging in Patients with Acute Myocardial Infarction. Presented at: TCT 2020. October 14, 2020.

28 28 Stone GW, Maehara A, Ali ZA, et al. PROSPECT ABSORB Investigators. Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. J Am Coll Cardiol. 2020 Nov 17; 76(20):2289–2301. doi: 10.1016/j.jacc.2020.09.547. Epub 2020 Oct 15. PMID: 33069847.

29 29 Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2‐year follow‐up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010; 56(3): 177–184. PubMed PMID: 20537493.

30 30 De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve‐guided PCI for stable coronary artery disease. N Engl J Med 2014; 371(13): 1208–1217. PubMed PMID: 25176289.

31 31 Han JK, Koo BK, Park KW, et al. Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study. Cardiology 2014; 127(4): 256–262. PubMed PMID: 24480866.

32 32 Ma YF, Fam JM, Zhang BC. Critical analysis of the correlation between optical coherence tomography versus intravascular ultrasound and fractional flow reserve in the management of intermediate coronary artery lesion. Int J Clin Exp Med 2015; 8(5): 6658–6667. PubMed PMID: 26221203. Pubmed Central PMCID: 4509148.

33 33 Waksman R, Legutko J, Singh J, et al. FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study. J Am Coll Cardiol 2013; 61(9): 917–923. PubMed PMID: 23352786.

34 34 Nascimento BR, de Sousa MR, Koo BK, et al. Diagnostic accuracy of intravascular ultrasound‐derived minimal lumen area compared with fractional flow reserve— meta‐analysis: pooled accuracy of IVUS luminal area versus FFR. Catheter Cardiovasc Interv 2014; 84(3): 377–385. PubMed PMID: 23737441.

35 35 Case BC, Yerasi C, Forrestal BJ, et al. Intravascular ultrasound guidance in the evaluation and treatment of left main coronary artery disease. Int J Cardiol. 2021 Feb 15; 325:168–175. doi: 10.1016/j.ijcard.2020.10.008. Epub 2020 Oct 8. PMID: 33039578.

36 36 Ahmed JM, Mintz GS, Weissman NJ, et al. Mechanism of lumen enlargement during intracoronary stent implantation: an intravascular ultrasound study. Circulation 2000; 102(1): 7–10. PubMed PMID: 10880407.

37 37 Maehara A, Takagi A, Okura H, et al. Longitudinal plaque redistribution during stent expansion. Am J Cardiol 2000; 86(10): 1069–1072. PubMed PMID: 11074201.

38 38 Prati F, Pawlowski T, Gil R, et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation 2003; 107(18): 2320–2305. PubMed PMID: 12707236.

39 39 Guo N, Maehara A, Mintz GS, et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONSAMI) trial. Circulation 2010; 122:1077–1084.

40 40 Hong M‐K, Mintz GS, Lee CW, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus‐eluting stent implantation. Eur Heart J 2006; 27:1305–1310.

41 41 Doi H, Maehara A, Mintz GS, et al. Impact of post‐intervention minimal stent area on 9‐month follow‐up patency of paclitaxel‐eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. J Am Coll Cardiol Intv 2009; 2:1269–1275.] ou colocar apenas CONSENSUS PART1.

42 42 Choi S‐Y, Witzenbichler B, Maehara A, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) substudy. Circ Cardiovasc Interv 2011; 4:239–247.

43 43 Kang S‐J, Ahn J‐M, Song H, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv 2011; 4:562–569.

44 44 Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long‐term results following sirolimus‐eluting stent implantation: serial intravascular ultrasound analysis from the Sirius Trial. J Am Coll Cardiol 2004; 43:1959–1963.

45 45 Song H‐G, Kang S‐J, Ahn J‐M, et al. Intravascular ultrasound assessment of optimal stent area to prevent in‐stent restenosis after zotarolimus‐, everolimus‐, and sirolimus‐eluting stent implantation. Catheter Cardiovasc Interv 2014; 83:873–878.]

46 46 Mintz GS. Intravascular ultrasound guidance improves patient survival (mortality) after drug‐eluting stent implantation: review and updated bibliography Gary S. Mintz. Cardiovasc Interv Ther. 2020 Jan; 35(1):37–43.

47 47 Ahn JM, Kang SJ, Yoon SH, et al. Meta‐analysis of outcomes after intravascular ultrasound‐guided versus angiography‐guided drug‐eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol 2014; 113(8): 1338–1347. PubMed PMID: 24685326.

48 48 Malik AH, Yandrapalli S, Aronow WS, et al. Intravascular ultrasound‐guided stent implantation reduces cardiovascular mortality ‐ Updated meta‐analysis of randomized controlled trials. Int J Cardiol. 2020 Jan 15; 299:100–105. doi: 10.1016/j.ijcard.2019.07.033. Epub 2019 Jul 10. PMID: 31345647.

49 49 Shlofmitz E, Ali ZA, Maehara A, et al. Intravascular Imaging‐Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation. Circ Cardiovasc Interv. 2020 Dec; 13(12):e008686. doi: 10.1161/CIRCINTERVENTIONS.120.008686. Epub 2020 Nov 25. PMID: 33233934.

50 50 Park SJ, Kim YH, Park DW, et al. MAIN‐COMPARE Investigators. Impact of intravascular ultrasound guidance on long‐term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009 Jun; 2(3):167–77. doi: 10.1161/CIRCINTERVENTIONS.108.799494. Epub 2009 Apr 21. PMID: 20031713.

51 51 de la Torre Hernandez JM, Baz Alonso JA, Gómez Hospital JA, et al. IVUS‐TRONCO‐ICP Spanish study. Clinical impact of intravascular ultrasound guidance in drug‐eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient‐level of 4 registries. JACC Cardiovasc Interv. 2014 Mar; 7(3):244–54. doi: 10.1016/j.jcin.2013.09.014. PMID: 24650399.

52 52 Gao XF, Kan J, Zhang YJ, et al. Comparison of one‐year clinical outcomes between intravascular ultrasound‐guided versus angiography‐guided implantation of drug‐eluting stents for left main lesions: a single‐center analysis of a 1,016‐patient cohort. Patient Prefer Adherence. 2014; 8:1299–309.]

53 53 Andell P, Karlsson S, Mohammad MA, et al. Intravascular Ultrasound Guidance Is Associated With Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared With Angiography Guidance Alone. Circ Cardiovasc Interv. 2017; 10:e004813.

54 54 Choi KH, Song YB, Lee JM, et al. Impact of Intravascular Ultrasound‐Guided Percutaneous Coronary Intervention on Long‐Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC Cardiovasc Interv. 2019; 12:607–20.

55 55 Kinnaird T, Johnson T, Anderson R, et al. Intravascular Imaging and 12‐Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database. JACC Cardiovasc Interv. 2020; 13:346–57.

56 56 Mariani J Jr, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv. 2014 Nov; 7(11):1287–93. doi: 10.1016/j.jcin.2014.05.024. Epub 2014 Oct 15. PMID: 25326742; PMCID: PMC4637944.

57 57 Ali ZA, Karimi Galougahi K, Nazif T, et al. Imaging‐ and physiology‐guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J. 2016; 37:3090–3095. doi: 10.1093/eurheartj/ehw078 31.

58 58 Karimi Galougahi K, Zalewski A, Leon MB, et al. Optical coherence tomography‐guided percutaneous coronary intervention in preterminal chronic kidney disease with no radio‐contrast administration. Eur Heart J. 2016; 37:1059. doi: 10.1093/eurheartj/ehv667.

Interventional Cardiology

Подняться наверх